Vallon Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update - Company continues to drive enrollment in pivotal intranasal abuse study evaluating ADAIR toward completion before year-end 2021 - ADAIR targeting the large and growing Adderall® segment of the...